Jin Kang

Affiliations: 
2022- School of Resource and Environmental Sciences Wuhan University, Wuhan Shi, Hubei Sheng, China 
Google:
"Jin Kang"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang Y, Wei S, Kang JU. (2023) Depth-dependent attenuation and backscattering characterization of optical coherence tomography by stationary iterative method. Journal of Biomedical Optics. 28: 085002
Yun R, Hong E, Kim J, et al. (2023) N-linked glycosylation is essential for anti-tumor activities of KIAA1324 in gastric cancer. Cell Death & Disease. 14: 546
Wang Q, Xu C, Wang W, et al. (2023) Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma. Thoracic Cancer
Lee KH, Cho BC, Ahn MJ, et al. (2023) Lazertinib versus Gefitinib as First-line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset. Cancer Research and Treatment
Cho BC, Ahn MJ, Kang JH, et al. (2023) Lazertinib Versus Gefitinib as First-line Treatment in Patients With -mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Results From LASER301. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 101200JCO2300515
Kang JS. (2023) Changing Trends in the Incidence and Clinical Features of Pneumonia in Non-HIV Patients before and during the COVID-19 Era and Risk Factors for Mortality between 2016 and 2022. Life (Basel, Switzerland). 13
Ko DS, Baek SE, Ha M, et al. (2023) Osteopontin is a key regulator of vascular smooth muscle cell proliferation in the outflow vein of arteriovenous fistulas. Microvascular Research. 104570
Khanduja S, Kim J, Kang JK, et al. (2023) Hypoxic-Ischemic Brain Injury in ECMO: Pathophysiology, Neuromonitoring, and Therapeutic Opportunities. Cells. 12
Xiong D, Zhao J, Qiu Y, et al. (2023) 3D structural human interactome reveals proteome-wide perturbations by disease mutations. Biorxiv : the Preprint Server For Biology
Yoon S, Kim M, Hong YS, et al. (2023) ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group. Cancer Research and Treatment
See more...